Clinical case seminar: Recombinant thyrotropin-induced orbital uptake of [111in-diethylenetriamine-pentacetic acid-D-phe1] octreotide in a patient with inactive graves' ophthalmopathy

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 4, 2005, Pages 2440-2444

  Savastano, Silvia ^a   Pivonello, Rosario ^a   Acampa, Wanda ^a   Salvatore, Marco ^a   Lombardi, Gaetano ^a   Colao, Annamaria ^a   Fenzi, Gianfranco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO PHENYLALANINE OCTREOTIDE PENTETATE INDIUM IN 111; METHYLPREDNISOLONE; RADIOPHARMACEUTICAL AGENT; RECOMBINANT THYROTROPIN; SOMATOSTATIN RECEPTOR; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; OCTREOTIDE; PENTETIC ACID; RECOMBINANT PROTEIN; SDZ 215 811; SDZ 215-811; THYROTROPIN;

ADULT; CASE REPORT; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG UPTAKE; ENDOCRINE OPHTHALMOPATHY; EYE MOVEMENT; EYE PAIN; FEMALE; FIBROBLAST; FOLLOW UP; HUMAN; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCINTIGRAPHY; THYROID PAPILLARY CARCINOMA; ARTICLE; GRAVES DISEASE; METABOLISM; MIDDLE AGED; ORBIT; PHYSIOLOGY; SCINTISCANNING;

FEMALE; GRAVES DISEASE; HUMANS; INDIUM RADIOISOTOPES; MIDDLE AGED; OCTREOTIDE; ORBIT; PENTETIC ACID; RADIOPHARMACEUTICALS; RECEPTORS, THYROTROPIN; RECOMBINANT PROTEINS; THYROTROPIN;

EID: 17844362976     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-2135     Document Type: Conference Paper

References (40)

1. Burch HB, Wartofsky L 1993 Graves' opthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 14:747-793
2. Prummel MF 2000 Graves' ophthalmopathy: diagnosis and management. Eur J Nucl Med 27:373-376
3. Bahn RS 2003 Pathophysiology of Graves' ophthalmopathy: the cycle disease. J Clin Endocrinol Metab 88:1939-1946
4. Bartalena L, Pinchera A, Marcocci C 2000 Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 21:168-199
5. Heufelder AE 2000 Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disord 1:87-95
6. Wiersinga WM, Prummel MF 2001 Pathogenesis of Graves' ophthalmopathy-current understanding. J Clin Endocrinol Metab 86:501-503
7. Kendall-Taylor P 1998 Current management of thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf) 49:11-12
8. Reubi JC, Maurer R 1985 Autoradiographic mapping of somatostatin receptors in the rat CNS and pituitary. Neuroscience 15:1183-1193
9. Patel YC, Amherdt M, Orci L 1982 Quantitative electron microscopic autoradiography of insulin, glucagons and somatostatin binding sites on islets. Science 217:1155-1156
10. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ 1989 Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 264:949-953
11. Krenning EP, Bakker WH, Breeman WA, Koper JW, Kooij PP, Ausema L, Lameris J, Reubi JC, Lamberts SW 1989 Localization of endocrine-related tumors with radioiodinated analogue of somatostatin. Lancet 1:242-245
12. Lamberts SW, Bakker WH, Reubi JC, Krenning EP 1990 Somatostatin receptor imaging. N Engl J Med 323:1246-1249
13. van Hagen PM, Krenning EP, Kwekkeboom DJ, Reubi JC, Anker-Lugtenburg PJ, Lowenberg P, Lamberts SW 1994 Somatostatin in the immune and hematopoietic system: a review. Eur J Clin Invest 24:91-99
14. 1]-ocrreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity? J Clin Endocrinol Metab 79:1845-1851
15. Kahaly C, Diaz M, Hahn K, Beyer J, Bockisch A 1995 Indium-111- pentetreotide scintigraphy in Graves' ophthalmopathy. J Nucl Med 36:550-554
16. Krassas GE, Dumas A, Pontikides N, Kaltsas TH 1995 Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol (Oxf) 42:571-580
17. Krassas GE, Kaltsas TH, Dumas A, Pontikides N, Tolis G 1997 Lanreotide in the treatment of patients with thyroid eye disease. Eur J Endocrinol 36:416-422
18. 1]- octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 83:3790-3794
19. Belfiore A, Russo D, Vigneri R, Filetti S 2001 Graves' disease, thyroid nodules and thyroid cancer. Clin Endocrinol (Oxf) 55:711-718
20. Gabriele R, Letizia C, Borhgese M, De Toma G, Celi M, Izzo L, Cavallaro A 2003 Thyroid cancer in patients with hyperthyroidism. Horm Res 60:79-83
21. Wiersinga WM, Prummel MF, Mourits MP, Koornneef L, Buller HR 1991 Classification of the eye changes of Graves' disease. Thyroid 1:357-360
22. Anonymous 1992 Classification of eye changes of Graves' disease. Thyroid 2:235-236
23. 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 49:1583-1591
24. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78
25. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri A, Cartei F, Nardi M, Pinchera A 2001 Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab 86:3562-3567
26. Mounts MP, Prummel MF, Wiersinga WM, Koornneef L 1997 Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 47:9-14
27. Smith TJ 2002 Fibroblast biology in thyroid diseases. Curr Opin Endocrinol Diabet 9:393-400
28. Perros P, Kendall-Taylor P 1998 Natural history of thyroid eye disease. Thyroid 8:423-425
29. Feliciello A, Porcellini A, Ciullo I, Bonavolontà G, Avvedimento EV, Fenzi G 1993 Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342:337-338
30. Wakelkamp IM, Bekker O, Baldeschi L, Wiersinga WM, Prummel MF 2003 TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) 58:280-287
31. Many MC, Costagliola S, Detrait M, Denef JF, Vassart G, Ludgate M 1999 Development of an animal model of autoimmune thyroid eye disease. J Immunol 162:4966-4974
32. Hansson HA, Petruson B, Skottnerm A 1986 Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin. Lancet 1:218-219
33. Pasquali D, Vassallo P, Esposito D, Bonavolontà G, Bellastella A 2000 Somatostatin receptor expression and effects of octreotide in cultured retroorbital cells from patients with Graves' ophthalmopathy. J Mol Endocrinol 25:63-71
34. Pasquali D, Notaro A, Bonavolontà G, Vassallo P, Bellastella A, Sinisi AA 2002 Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves' disease. J Clin Endocrinol Metab 87:5125-5129
35. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC 1995 Somatostatin receptor scintigraphy. In: Freeman LM, ed. Nuclear medicine annual. New York: Raven Press Ltd.; 1-50
36. Colao A, Pivonello R, Lastoria S, Faggiano A, Ferone D, Lombardi G, Fenzi G 2000 Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease. Eur J Endocrinol 143:535-842
37. Bartalena L, Marcocci C, Pinchera A 2004 Somatostatin analogs for Graves' ophthalmopathy: do they bounce off like a rubber bullet? J Clin Endocrinol Metab 89:5908-5909 (Editorial)
38. Moleti M, Mattina F, Salamone I, Violi MA, Nucera C, Baldari S, Lo Schiavo MG, Regalbuto C, Trimarchi F, Vermiglio F 2003 Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of Graves' ophthalmopathy. Thyroid 13:653-658
39. 4 by rh-TSH. Proc International Workshop on Graves' Ophthalmopathy, Lipari, Italy, 2004, p 64 (Abstract)
40. Torres MST, Ramirez L, Simkin PH, Braverman LE, Emerson CE 2001 Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 86:1660-1664